O TYM ODCINKU

Język angielski
Stany Zjednoczone

TRANSKRYPCJA 🔗

WYSZUKAJ MINIONE ODCINKI

Wyszukaj minione odcinki Therapeutic Momentum.

INNE ODCINKI W TYM PODCASCIE

Andy Plump discusses his journey from a postdoc at UCSF to a leading roles in pharmaceutical research. Andy, who joined Merck in 2001, worked in clinical pharmacology. He highlighted the importance of genetics in target selection and shares his experiences at Sanofi and Takeda, emphasizing the cult…
Mathai Mammen is a world-renowned innovator in drug discovery, development, and team- and company-building responsible for creating 13 transformational medicines from discovery through commercial launch and more than 25 other potential medicines that have achieved clinical proof-of-concept, many of…
Dame Catherine Elizabeth "Kate" Bingham is a British biochemist and life‑sciences venture capitalist. She earned a first‑class MA in Biochemistry from Oxford and an MBA (Baker Scholar) from Harvard. Since 1991, she has been a managing partner at SV Health Investors, co‑founding the Dementia Discove…
The Therapeutic Momentum podcast series illuminates the inspiring personal stories, touchstone moments, and transformational events that fuel the relentless pursuit of life-changing treatments. It reveals the intricate tapestry of experiences that drive people in the biomedical field who share the …
Coronary heart disease is no longer a mystery. Listen to the story of one of medicine’s greatest triumphs — a battle fought in labs, clinics, kitchens, and boardrooms. This is the story of cholesterol. And how we turned a silent killer into a preventable disease.
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z Therapeutic Momentum, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.